Regional research offices
Chuck Howard - Patient story
Julie Randall - Patient story
Tara Foote - Provider story
If you have questions about clinical trials or want help finding the right one for you, contact our:
Patient Engagement Center Phone: 844-552-2734
This is a preliminary search of all open and enrolling clinical trials across our regions and affiliate organizations that have sponsors' permission to publish to this website.
Please use the filtering options in the right column to refine your search. Otherwise ALL open and enrolling clinical trials will display below.
Observational study in the routine clinical practice setting to evaluate the short and long term safety profile of Radium-223 in metastatic...
This is a randomized, phase II study of IL-2 and SBRT in patients with metastatic renal cancer.
* Histological confirmation of...
The purpose of this study is to determine the efficacy and safety of pembrolizumab (MK-3475) with or without chemotherapy versus chemotherapy alone...
PART 1: The primary objective of this study is to identify the maximum tolerated dose (MTD) of PT2385 Tablets and/or the recommended Phase 2 dose...
This randomized phase III trial studies androgen-deprivation therapy and radiation therapy in treating patients with prostate cancer.
The Pacific Cancer Research Consortium clinical trials are offered at multiple locations throughout Oregon, Washington, Alaska, California, and Idaho. To find a location near you, please contact the Patient Engagement Center at 844-552-2734.